Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07214597

NICU Utilization of Remote Voice Technology to Improve mateRnal Experience (NURTURE)

The study's objective is to conduct a Phase II randomized controlled trial examining the preliminary efficacy of the VoiceLove app compared to usual care on maternal postpartum depression in mothers with infants admitted to the Neonatal Intensive Care Unit (NICU). Primary aim: Assess the effects of VoiceLove on maternal postpartum depression, measured by the Edinburgh Postnatal Depression Scale (EPDS). The estimates from this study will be used for a future definitive Phase III trial. Secondary aim: Assess feasibility, acceptability, and patterns of communication and engagement among mothers, partners, and NICU clinicians during the NICU hospitalization, measured through app usage metrics, satisfaction surveys, and qualitative interviews. Additionally, we will evaluate effects of infant length of stay.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Vanderbilt University Medical Center

Nashville, Tennessee, 37232, United States

Location status: Recruiting

Location contact

Makenna Woods

CONTACT

[email protected]

615-936-2938

Sarah Osmundson

PRINCIPAL_INVESTIGATOR

About this study

This study is a randomized control trial that will test VoiceLove, a secure mobile app designed to help families communicate with their infants in the Neonatal Intensive Care Unit (NICU).

Postpartum depression (PPD) is a major depressive disorder and is one of the most frequent childbirth complications. Mother-infant separation during the initial postpartum period, such as infant admission to the neonatal intensive care unit (NICU), impacts mother-infant bonding and increases PPD risk, which is 40% higher in mothers with children admitted to the NICU. The impact of PPD is substantial: reported poor quality of life, high-risk behaviors such as substance abuse or self-harm, and long-term impairments in child cognitive and emotional development. PPD impact on child development has potential to be magnified in the already vulnerable preterm infant population. Care in the NICU is, by design, focused on the health of the infant and ill-equipped to address parental mental health. High stress and burnout among NICU staff combined with limited resources for development of psychosocial programs targeting the parents of NICU patients underscore the need for simple, low-cost, and easily implemented interventions aimed at improving parental connectedness and reducing postpartum mental health disorders.

Lack of parental connectedness to their neonate during a NICU stay and low social support are two of the most powerful risk factors for developing PPD. Risk of PPD is decreased when parents have more contact, either physical or verbal, with their infant and a higher perceived social support system. When physical contact is not possible, voice contact may help foster feelings of connectedness to both the infant in the NICU, and to the parents' social circle. The medical team is another critical source of support poised to increase parental mental health. Mothers of infants in the NICU report increased depressive symptoms when their perception of nurse support is low, while increased communication between parents and the medical team improves parental well-being. Increased social support from loved ones and the medical care team is well positioned to significantly reduce PPD severity in parents of NICU infants. Thus, facilitation of communication between parents and healthcare providers, as well as between their friends and family, presents a low-cost, low effort means to dramatically impact parental mental health and well-being during a NICU admission.

VoiceLove Inc has developed a novel HIPAA-compliant mobile application that offers programmatic support and curated digital content (e.g., lullabies, music, environmental sounds) for infant-family interactions and enables expanded family engagement in hospital settings. VoiceLove mobile app circumvents barriers to communication through an electronic venue for direct patient-family-clinician interaction. Specifically for clinicians, VoiceLove is a safe and time-efficient tool for direct communication with absent family members, allowing more time for direct patient care.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Infant:
  • Admitted to the neonatal intensive care unit (NICU)
  • Not readmitted after discharge from the NICU
  • Expected to survive at least 2 weeks
  • Expected to be admitted to the NICU for at least 2 weeks
  • Singleton gestation
  • Mother:
  • Age ≥ 18 years old
  • English speaking
  • Mother is the biological mother of the infant admitted to the NICU
  • Postpartum day 4 or less
  • Partner (NOTE: Partner enrollment is not required)
  • Mother agrees to partner's participation
  • Designated by mother as support person with infant access

Exclusion criteria

  • Infant

a. Re-admission to NICU

  • Mother
  • No access to an Android or iOS smartphone
  • Unwilling to download the VoiceLove NICU app to their personal smartphone and unwilling to accept the terms and conditions of the VoiceLove app
  • No personal email address
  • Incarcerated at time of delivery or postpartum
  • Inability to obtain informed consent

i. Patient's clinician refuses enrollment of the patient ii. Patient is either mentally (acute psychosis) or physically (intubated or critically ill in the ICU) unable to provide informed consent f. Unable to approach the patient (staffing, patient unavailable) g. Mother is not the intended parent (plans adoption, is a surrogate, will not have custody of the infant)

  • Partner (NOTE: Partner enrollment is not required)
  • Age < 18 years old
  • Not English speaking
  • Inability to obtain informed consent
  • No access to an Android or iOS smartphone that is different from the mother's smartphone
  • No access to an email address that is different from the mother's email address
  • Unwilling to download the VoiceLove NICU app to their personal smartphone and unwilling to accept the terms and conditions of the VoiceLove app

Treatment and study plan

VoiceLove mobile phone application

Device

Access to VoiceLove app to facilitate secure, real-time communication between family members and NICU patients.

Other names: VoiceLove app

Primary outcomes

  1. Patient Engagement with the VoiceLove App

    Time frame: 2-weeks post randomization.

    To assess the feasibility of using the VoiceLove app, we will measure how much patients in the intervention group engage with the app using metrics such as average app use per day at 2-weeks post randomization.

  2. Edinburgh Postnatal Depression Score (EPDS) at 2-weeks post randomization.

    Time frame: 2-weeks post randomization.

    The EPDS is a 10-question assessment of postpartum depression measured continuously on a scale of 1 to 30, whereas a higher score is a higher indication of postpartum depression.

Secondary outcomes

  1. EPDS Score at 6-weeks post randomization

    Time frame: 6-weeks post randomization.

    The EPDS is a 10-question assessment of postpartum depression measured continuously on a scale of 1 to 30, whereas a higher score is a higher indication of postpartum depression.

  2. Prevalence of high risk for postpartum depression (EPDS score ≥ 13) at 2- and 6-weeks.

    Time frame: 2- and 6-weeks post randomization

    Edinburgh Postnatal Depression Score (EPDS) ≥ 13. The EPDS is a 10-question assessment of postpartum depression measured continuously on a scale of 1 to 30, whereas a higher score is a higher indication of postpartum depression.

  3. PROMIS Informational Support at 2- and 6-weeks post randomization

    Time frame: 2- and 6-weeks post randomization

    Patient-Reported Outcomes Measurement Information System (PROMIS). According to HealthMeasures, the following describes the PROMIS Informational Support: "Quality of social support refers to functional aspects of supportive relationships, i.e., interpersonal relationships that serve particular functions. This includes the interactive process by which emotional, instrumental or informational support is obtained from one's social network. It also includes companionship, feeling cared for and valued as a person, communication with others, and feelings of belonging and trust. Measures of social support generally seek information about a person's perception of the availability or adequacy of resources provided by others.

    The bank assesses perceived availability of helpful information or advice. The item bank does not use a time frame (e.g. over the past seven days) when assessing informational support. Informational Support instruments are available for adults (ages 18+)."

  4. PROMIS Self-Efficacy at 2- and 6-weeks post randomization

    Time frame: 2- and 6-weeks post randomization

    Patient-Reported Outcomes Measurement Information System (PROMIS) Self-Efficacy is described as the following according to HealthMeasures: "an individual's confidence in his/her ability to successfully perform specific tasks or behaviors related to one's health in a variety of situations. The PROMIS adult Self-Efficacy item banks assess self-reported current level of confidence in managing chronic conditions, including confidence in managing daily activities, managing emotions, managing medications and treatments, managing social interactions and managing symptoms. The self-efficacy item banks are universal rather than disease-specific. The respondent should be an adult (age 18+) and have at least one chronic health condition."

  5. Generalized Anxiety Disorder 7-item (GAD 7) at 2- and 6-weeks post randomization

    Time frame: 2- and 6-weeks post randomization

    The Generalized Anxiety Disorder 7-item (GAD 7) is a seven item questionnaire, whereas a higher score is a higher indication of generalized anxiety disorder.

  6. Post Traumatic Stress Disorder Checklist (PCL-5) at NICU discharge

    Time frame: at infant's NICU discharge, up to six (6) months.

    According to the National Center for PTSD, the Post Traumatic Stress Disorder Checklist (PCL-5) is described as the following: "The PCL-5 is a 20-item self-report measure that assesses the 20 DSM-5 symptoms of PTSD. The PCL-5 has a variety of purposes, including:

    • Monitoring symptom change during and after treatment
    • Screening individuals for PTSD
    • Making a provisional PTSD diagnosis The gold standard for diagnosing PTSD is a structured clinical interview such as the Clinician-Administered PTSD Scale (CAPS-5). When necessary, the PCL-5 can be scored to provide a provisional PTSD diagnosis."
  7. NICU length of stay

    Time frame: from NICU admission to NICU discharge, up to six (6) months.

    Length of stay for the infant admitted to the Neonatal Intensive Care Unit (NICU) until they are discharged from the NICU.

  8. Infant birth weight at NICU discharge

    Time frame: from NICU admission to NICU discharge, up to six (6) months.

    Weight of the infant admitted to the Neonatal Intensive Care Unit (NICU) at time of their NICU discharge.

  9. App Usability and Satisfaction Scale at 2- and 6-weeks post randomization

    Time frame: 2- and 6-weeks post randomization

    A 5-point Likert scale and open-ended survey intended to analyze responses from those randomized to the intervention group.

Other outcomes

  1. Clinically meaningful infant outcomes

    Time frame: From randomization through discharge, up to 6 months.

    Intraventricular hemorrhage (IVH), patent ductus arteriosus (PDA), sepsis, necrotizing enterocolitis (NEC), chronic lung disease (CLD)

  2. Infant short-term outcomes

    Time frame: From randomization through discharge, up to 6 months.

    hearing test results

  3. Infant short-term outcomes

    Time frame: From randomization through discharge, up to 6 months.

    length of stay

  4. NICU Discharge Survey Results

    Time frame: Within 48 hours of NICU discharge, the survey will be completed.

    Results of the NICU Discharge Survey that were submitted by maternal participants. The survey contains questions about mode of infant feeding, and scaled and open-ended questions about their perception of communication and engagement with their health care team.

Study contacts

Contact information is provided by the study sponsor or research team.

Makenna Woods

CONTACT

[email protected]

615-936-2938

Sponsors and collaborators

Lead sponsor

Vanderbilt University Medical Center

Other

Collaborators

  • National Institute of Mental Health (NIMH)

Registry information

Official study title

NICU Utilization of Remote Voice Technology to Improve mateRnal Experience (NURTURE): A Randomized Controlled Trial

Acronym: NURTURE

Important dates

Study start
2026
Primary completion
2028
Study completion
2028
First posted
Oct 9, 2025
Registry last updated
Jun 17, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.